596 related articles for article (PubMed ID: 29342991)
1. [An analysis of clinical characteristics and acute treatment of supraventricular tachycardia in children from a multicenter study].
Li XM; Ge HY; Liu XQ; Shi L; Guo BJ; Li MT; Jiang H; Zhang Y; Liu HJ; Zheng XC; Li AJ; Zhang YY
Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):13-18. PubMed ID: 29342991
[No Abstract] [Full Text] [Related]
2. [Clinical course and treatment of ectopic atrial tachycardia in 144 children].
Ge H; Li X; Zhang Y; Liu H; Jiang H
Zhonghua Er Ke Za Zhi; 2015 Mar; 53(3):214-9. PubMed ID: 26165020
[TBL] [Abstract][Full Text] [Related]
3. Comparison of adenosine effects on atrioventricular node reentry and atrioventricular reciprocating tachycardias.
Donahue JK; Orias D; Berger RD; Tomaselli GF; Lawrence JH; Calkins H
Clin Cardiol; 1998 Oct; 21(10):743-5. PubMed ID: 9789695
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
Luedtke SA; Kuhn RJ; McCaffrey FM
Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
[TBL] [Abstract][Full Text] [Related]
5. Follow-up of children or teenagers with paroxysmal supraventricular tachycardia, but without pre-excitation syndrome.
Brembilla-Perrot B; Olivier A; Villemin T; Manenti V; Vincent J; Moulin-Zinsch A; Lethor JP; Tisserant A; Marçon F; Jean Marc S
Arch Cardiovasc Dis; 2017 Nov; 110(11):599-606. PubMed ID: 28751003
[TBL] [Abstract][Full Text] [Related]
6. Safety issues in the treatment of paediatric supraventricular tachycardias.
Pfammatter JP; Bauersfeld U
Drug Saf; 1998 May; 18(5):345-56. PubMed ID: 9589846
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological therapy in children with nodal reentry tachycardia: when, how and how long to treat the affected patients.
Bouhouch R; El Houari T; Fellat I; Arharbi M
Curr Pharm Des; 2008; 14(8):766-9. PubMed ID: 18393876
[TBL] [Abstract][Full Text] [Related]
8. AV nodal reentrant tachycardia or AV reentrant tachycardia using a concealed bypass tract-related adverse events.
Brembilla-Perrot B; Bénichou M; Brembilla A; Bozec E; Dorlet S; Sellal JM; Olivier A; Manenti V; Villemin T; Beurrier D; Moulin-Zinsch A; De Chillou C; Girerd N
Int J Cardiol; 2015 Nov; 199():84-9. PubMed ID: 26188825
[TBL] [Abstract][Full Text] [Related]
9. Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil.
Brady WJ; DeBehnke DJ; Wickman LL; Lindbeck G
Acad Emerg Med; 1996 Jun; 3(6):574-85. PubMed ID: 8727628
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine: therapeutic use for the termination of reentrant supraventricular tachycardia.
Chrysostomou C; Morell VO; Wearden P; Sanchez-de-Toledo J; Jooste EH; Beerman L
Congenit Heart Dis; 2013; 8(1):48-56. PubMed ID: 22613357
[TBL] [Abstract][Full Text] [Related]
11. [The study of acute clinical electrophysiological effects of propafenone on paroxysmal supraventricular tachycardia using transesophageal atrial pacing technique].
Li Q; Wang Z; Peng D
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(2):123-6. PubMed ID: 9868052
[TBL] [Abstract][Full Text] [Related]
12. Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Manz M; Lüderitz B
Eur Heart J; 1993 Sep; 14 Suppl E():91-8. PubMed ID: 8223763
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
Luedtke SA; Kuhn RJ; McCaffrey FM
Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
[TBL] [Abstract][Full Text] [Related]
14. Interactions of esmolol and adenosine in atrioventricular nodal-dependent supraventricular tachycardia: implication for the cellular mechanisms of adenosine.
Chang KC; Lin YC; Chen JY; Chou HT; Hung JS
Cardiology; 2002; 97(3):138-46. PubMed ID: 12077566
[TBL] [Abstract][Full Text] [Related]
15. Supraventricular tachycardia in infants, children and adolescents: diagnosis, and pharmacological and interventional therapy.
Paul T; Bertram H; Bökenkamp R; Hausdorf G
Paediatr Drugs; 2000; 2(3):171-81. PubMed ID: 10937468
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological effects, efficacy and safety of intravenous propafenone in termination of atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia: a prospective non-randomized interventional study.
Pintarić H; Manola S; Nossan JS; Pavlović N; Delić-Brkljacić D; Radeljić V
Acta Clin Croat; 2010 Mar; 49(1):25-31. PubMed ID: 20635581
[TBL] [Abstract][Full Text] [Related]
17. Optimal dose of adenosine effective for supraventricular tachycardia in children.
Qureshi AU; Hyder SN; Sheikh AM; Sadiq M
J Coll Physicians Surg Pak; 2012 Oct; 22(10):648-51. PubMed ID: 23058149
[TBL] [Abstract][Full Text] [Related]
18. Oral flecainide is effective in management of refractory tachycardia in infants.
Kohli V
Indian Heart J; 2013; 65(2):168-71. PubMed ID: 23647896
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of atenolol for atrioventricular reciprocating tachycardia in children less than 5 years old.
Ko JK; Ban JE; Kim YH; Park IS
Pediatr Cardiol; 2004; 25(2):97-101. PubMed ID: 14648002
[TBL] [Abstract][Full Text] [Related]
20. Acute Management of Refractory and Unstable Pediatric Supraventricular Tachycardia.
Lewis J; Arora G; Tudorascu DL; Hickey RW; Saladino RA; Manole MD
J Pediatr; 2017 Feb; 181():177-182.e2. PubMed ID: 27912926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
